Johnson & Johnson
Johnson & Johnson recalls more Tylenol
October 21, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls
Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …
Cutting-edge cancer treatments showcased at ESMO
October 18, 2010Research and Development AstraZeneca, Boehringer, Cancer, Cancer Conference, Johnson & Johnson, Novartis, personalised medicine
The search for a ‘silver bullet’ against cancer has failed, for now, with the battle against the disease turning instead …
J&J chief admits mistakes at Congressional hearing
October 1, 2010Sales and Marketing Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon admitted yesterday that his company had failed to maintain quality standards and mishandled …
J&J’s Weldon will appear at next congressional hearing
September 21, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson chief executive William Weldon will appear in person at the next congressional hearing on the company’s wide-ranging …
J&J to acquire Crucell for $2.3 billion
September 17, 2010Sales and Marketing Crucell, Johnson & Johnson
Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …
J&J and Merck heading for showdown over drug rights
September 8, 2010Sales and Marketing Johnson & Johnson, Merck, Remicade
Johnson & Johnson’s disagreement with Merck over rights to two arthritis drugs is set to come to a head in …
J&J recall plant will be closed all year
June 29, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The manufacturing facility at the centre of Johnson & Johnson’s product recall woes is likely to stay closed until at …
Congress summons J&J chief executive
June 23, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The Congressional committee looking into the recalls ordered by Johnson & Johnson unit McNeil Consumer Healthcare is planning to hold …
J&J expands recall of ‘musty’ products
June 18, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance
Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …
‘Phantom recall’ dogs J&J at congressional hearing
June 1, 2010Manufacturing and Production Johnson & Johnson, McNeil, Tylenol, manufacturing compliance
Johnson & Johnson subsidiary McNeil Consumer Healthcare initiated a recall of its painkiller Motrin (ibuprofen) last year without informing the …
Congress to probe McNeil’s GMP violations
May 7, 2010Manufacturing and Production Johnson & Johnson, McNeil, manufacturing compliance
The US Food and Drug Administration may take additional regulatory action against Johnson & Johnson subsidiary McNeil Consumer Healthcare over …
More quality issues dog J&J
May 5, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance, recalls
Johnson & Johnson’s manufacturing is under the spotlight at the FDA once again for quality issues affecting its products. At …
Cordis appoints Christian Spaulding
March 30, 2010Cordis, Johnson & Johnson, appointment, research and development
Johnson & Johnson’s vascular technology company Cordis has appointed Dr Christian Spaulding worldwide VP of medical affairs. He assumes the …
J&J strengthens biotech business
October 24, 2003Janssen, Janssen Cilag, Johnson & Johnson, Scios
Johnson & Johnson is to expand its biotech capabilities with a $2.4 billion purchase of US company Scios.The deal, still …
Latest content
Five Facts about cardiovascular disease
